BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32429487)

  • 1. Reproducibility of Ablated Volume Measurement Is Higher with Contrast-Enhanced Ultrasound than with B-Mode Ultrasound after Benign Thyroid Nodule Radiofrequency Ablation-A Preliminary Study.
    Schiaffino S; Serpi F; Rossi D; Ferrara V; Buonomenna C; Alì M; Monfardini L; Sconfienza LM; Mauri G
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32429487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
    Yan L; Luo Y; Xiao J; Lin L
    Eur Radiol; 2021 May; 31(5):3226-3236. PubMed ID: 33128600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation and agreement between superb micro-vascular imaging and contrast-enhanced ultrasound for assessing radiofrequency ablation treatment of thyroid nodules: a preliminary study.
    Lan Y; Li N; Song Q; Zhang MB; Luo YK; Zhang Y
    BMC Med Imaging; 2021 Nov; 21(1):175. PubMed ID: 34809604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study.
    Yan L; Li X; Xiao J; Li Y; Zhu Y; He H; Luo Y
    Int J Hyperthermia; 2022; 39(1):40-47. PubMed ID: 34936850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
    Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
    Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study.
    Yan L; Luo Y; Song Q; Li N; Xiao J; Zhang Y; Zhu Y
    Int J Hyperthermia; 2020 Nov; 37(1):1336-1344. PubMed ID: 33251890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of contrast-enhanced ultrasound and conventional ultrasound-guided radiofrequency ablation on benign thyroid nodules.
    Xu S; He H; Jiang M
    Pak J Med Sci; 2023; 39(6):1661-1665. PubMed ID: 37936746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superb Microvascular Imaging Compared with Contrast-Enhanced Ultrasound for Assessing Laser Ablation Treatment of Benign Thyroid Nodules.
    Liu W; Zhou P; Zhao Y; Tian S; Wu X
    Biomed Res Int; 2018; 2018():1025657. PubMed ID: 30671442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules.
    Choi YJ; Baek JH; Hong MJ; Lee JH
    Korean J Radiol; 2015; 16(3):560-5. PubMed ID: 25995685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation.
    Jiao Z; Luo Y; Song Q; Yan L; Zhu Y; Xie F
    BMC Med Imaging; 2020 Jul; 20(1):79. PubMed ID: 32664884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anhydrous Ethanol Improves Efficiency of Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules:A Prospective Randomized Controlled Trial].
    Zhu Y; Jin Z; Zhang Y; Jiang B; Yan L; Tian X; Zhang M; Luo Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):331-337. PubMed ID: 32616128
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
    Bernardi S; Cavallaro M; Colombin G; Giudici F; Zuolo G; Zdjelar A; Dobrinja C; De Manzini N; Zanconati F; Cova MA; Stacul F; Fabris B
    Front Endocrinol (Lausanne); 2020; 11():582550. PubMed ID: 33597921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional ultrasound VOCAL combined with contrast-enhanced ultrasound: an alternative to contrast-enhanced magnetic resonance imaging for evaluating ablation of benign uterine lesions.
    Zhang J; Lyu G; Qiu J; Qiu S; Li Z; Lin M; Xiao X; Tang L; He J; Li X; Li S
    Int J Hyperthermia; 2022; 39(1):1360-1370. PubMed ID: 36266251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules.
    Yan L; Luo Y; Xie F; Zhang M; Xiao J
    Int J Hyperthermia; 2020; 37(1):1139-1148. PubMed ID: 32996790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
    Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
    Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analysis of inter-observer and intra-observer variability in multi ultrasound descriptor assessment of thyroid nodules.
    Dobruch-Sobczak K; Migda B; Krauze A; Mlosek K; Słapa RZ; Wareluk P; Bakuła-Zalewska E; Adamczewski Z; Lewiński A; Jakubowski W; Dedecjus M
    J Ultrason; 2019 Nov; 19(78):198-206. PubMed ID: 31807325
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
    Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
    Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up.
    Guang Y; He W; Luo Y; Zhang H; Zhang Y; Ning B; Yu T
    BMC Cancer; 2019 Feb; 19(1):147. PubMed ID: 30760229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients.
    Zhao X; Wang W; Zhang S; Liu J; Zhang F; Ji C; Li X; Gan W; Zhang G; Guo H
    Abdom Imaging; 2012 Oct; 37(5):885-91. PubMed ID: 22131041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.